230 related articles for article (PubMed ID: 37743634)
21. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
[TBL] [Abstract][Full Text] [Related]
22. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
[TBL] [Abstract][Full Text] [Related]
23. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
[TBL] [Abstract][Full Text] [Related]
24. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
[TBL] [Abstract][Full Text] [Related]
26. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
[TBL] [Abstract][Full Text] [Related]
27. Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
Mery VP; Gros P; Lafontaine AL; Robinson A; Benedetti A; Kimoff RJ; Kaminska M
Neurology; 2017 Mar; 88(12):1120-1128. PubMed ID: 28228566
[TBL] [Abstract][Full Text] [Related]
28. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
[TBL] [Abstract][Full Text] [Related]
29. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
[TBL] [Abstract][Full Text] [Related]
31. Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson's Disease.
Zhang Z; Li S; Wang S
Int J Gen Med; 2023; 16():785-792. PubMed ID: 36879618
[TBL] [Abstract][Full Text] [Related]
32. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
33. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
34. Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.
Zhang JR; Chen J; Yang ZJ; Zhang HJ; Fu YT; Shen Y; He PC; Mao CJ; Liu CF
Chin Med J (Engl); 2016 Feb; 129(4):379-85. PubMed ID: 26879009
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson's disease].
Chao JY; Xiong KP; Zhuang S; Zhang JR; Huang JY; Li J; Mao CJ; Wu HH; Wang JY; Liu CF
Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2792-2797. PubMed ID: 34551496
[No Abstract] [Full Text] [Related]
36. Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.
Uchino K; Shiraishi M; Tanaka K; Akamatsu M; Hasegawa Y
PLoS One; 2017; 12(11):e0187616. PubMed ID: 29121638
[TBL] [Abstract][Full Text] [Related]
37. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
Goldman JG; Stebbins GT; Leung V; Tilley BC; Goetz CG
Parkinsonism Relat Disord; 2014 Nov; 20(11):1135-9. PubMed ID: 25150770
[TBL] [Abstract][Full Text] [Related]
38. Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
Yao Z; Shao Y; Han X
Neurosci Lett; 2017 Aug; 656():126-130. PubMed ID: 28698150
[TBL] [Abstract][Full Text] [Related]
39. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
